Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.
A location is a starting point. Ask the team whether that site is accepting people and whether you can take part from where you live.
About these summaries and listings
Introductions are AI-written from the registry in everyday language and have not been independently checked by a clinician. Open any study for its full name, original description and participation rules.
Studies name Parkinson’s or a related condition. Some include other conditions or healthy volunteers. Country filters include sites with matching or unreported recruitment status and exclude known closed sites.
Researchers are testing the Ronnie Gardiner Method in people with early to middle-stage Parkinson’s, looking at thinking, speech, balance, movement and mood.
Testing a treatment or activity
Age 18 years and over · Does not accept healthy volunteers
This study examines whether a supplement called tributyrin is safe and manageable for people with progressive supranuclear palsy, a condition distinct from Parkinson’s.
Testing a treatment or activity
Age 45 years and over · Does not accept healthy volunteers
Researchers compare taste and brain responses in people with early Parkinson’s, people with Lewy body disease, and volunteers without these conditions.
Testing a treatment or activity
Age 18 years and over · Also accepts healthy volunteers
Researchers compare two doses of the study medicine AP-472 with a look-alike inactive treatment in people whose movement symptoms fluctuate while taking levodopa.
Testing a treatment or activity
Ages 30 years to 80 years · Does not accept healthy volunteers
Researchers are learning how people experience periods when their Parkinson’s medicine wears off, and how they use the prescribed medicine Inbrija in everyday life.
Learning by observing or collecting information
Age 18 years and over · Does not accept healthy volunteers
Researchers are following people receiving foslevodopa and foscarbidopa in routine care to assess how the treatment works as Parkinson’s becomes more advanced.
Learning by observing or collecting information
Ages 18 years to 67 years · Does not accept healthy volunteers
This study tests NEU-411 in early Parkinson’s. A genetic test identifies people predicted to have increased activity in the biological pathway the medicine targets.
Testing a treatment or activity
Ages 40 years to 80 years · Does not accept healthy volunteers
The listings above come from ClinicalTrials.gov, which includes international studies. They are not an exhaustive worldwide list. Use WHO’s international search and these regional registries to find studies registered elsewhere. These links open separate registries; their records are not yet imported here.
Search for Parkinson disease and check recruitment status, local sites and eligibility. The same study can appear in several registries.